Lombard Odier Asset Management (Europe) LTD Amgen Inc Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

A detailed history of Lombard Odier Asset Management (Europe) LTD transactions in Amgen Inc stock. As of the latest transaction made, Lombard Odier Asset Management (Europe) LTD holds 18,971 shares of AMGN stock, worth $5 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

18,971

Previous 18,143 4.56%

Holding current value

$5 Million

Previous $5.67 Million 7.83%

% of portfolio

0.39%

Previous 0.39%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $256,166 - $279,350	828 Added 4.56%	18,971 $6.11 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $5,255 - $6,386	20 Added 0.11%	18,143 $5.67 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $6,452 - $7,789	-24 Reduced 0.13%	18,123 $5.15 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $819,518 - $924,514	3,205 Added 21.45%	18,147 $5.23 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $723,294 - $897,989	-3,308 Reduced 18.13%	14,942 $4.02 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $578,529 - $684,099	-2,700 Reduced 12.89%	18,250 $4.05 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $438,709 - $534,713	-1,943 Reduced 8.49%	20,950 $5.06 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $1.99 Million - $2.53 Million	-8,692 Reduced 27.52%	22,893 $6.01 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $701,437 - $791,093	-3,125 Reduced 9.0%	31,585 $7.12 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.47 Million - $2.75 Million	10,717 Added 44.67%	34,710 $8.45 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $453,888 - $502,119	-2,070 Reduced 7.94%	23,993 $5.8 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $5.18 Million - $5.93 Million	26,063 New	26,063 $5.86 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $531,628 - $589,802	-2,276 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $505,067 - $588,573	2,276 New	2,276 $566,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1.16 Million - $1.38 Million	-5,375 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $1.26 Million - $1.4 Million	5,375 New	5,375 $1.37 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.06 Million - $1.3 Million	-5,375 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $264,430 - $350,706	-1,451 Reduced 21.26%	5,375 $1.09 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $67,826 - $76,455	-375 Reduced 5.21%	6,826 $1.3 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $75,820 - $88,506	425 Added 6.27%	7,201 $1.4 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $233,643 - $273,042	-1,379 Reduced 16.91%	6,776 $1.16 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $120,178 - $134,276	-712 Reduced 8.03%	8,155 $1.42 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.48 Million - $1.69 Million	8,867	8,867 $1.65 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account

Lombard Odier Asset Management (Europe) LTD Amgen Inc Transaction History